19-54636748-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001081637.3(LILRB1):c.1829C>T(p.Ala610Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000137 in 1,610,714 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001081637.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LILRB1 | NM_001081637.3 | c.1829C>T | p.Ala610Val | missense_variant | 15/15 | ENST00000324602.12 | NP_001075106.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LILRB1 | ENST00000324602.12 | c.1829C>T | p.Ala610Val | missense_variant | 15/15 | 5 | NM_001081637.3 | ENSP00000315997.7 |
Frequencies
GnomAD3 genomes AF: 0.0000801 AC: 12AN: 149800Hom.: 0 Cov.: 28
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251392Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135892
GnomAD4 exome AF: 0.00000685 AC: 10AN: 1460914Hom.: 0 Cov.: 45 AF XY: 0.00000413 AC XY: 3AN XY: 726782
GnomAD4 genome AF: 0.0000801 AC: 12AN: 149800Hom.: 0 Cov.: 28 AF XY: 0.000123 AC XY: 9AN XY: 72910
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 18, 2023 | The c.1829C>T (p.A610V) alteration is located in exon 15 (coding exon 14) of the LILRB1 gene. This alteration results from a C to T substitution at nucleotide position 1829, causing the alanine (A) at amino acid position 610 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at